Technology & Science

FDA Reverses Feb-10 Refusal, Accepts Moderna mRNA-1010 Flu Vaccine for Review

Eight days after issuing a refusal-to-file letter, the FDA on 18 Feb 2026 agreed to review Moderna’s amended BLA for its mRNA-1010 seasonal flu shot, setting an Aug 5 decision deadline and split approval pathways for adults 50-64 (full) and 65+ (accelerated).